Clinical Trial Update: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity [Phase 3]

View source ↗

Summary

Phase 3 trial investigating semaglutide for overweight/obesity has completed; results were posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Metabolism and Nutrition Disorders
• Obesity
• Overweight

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Metabolism and Nutrition Disorder, Obesity | Phase 3 | Status: COMPLETED | Results posted: 2021-03-15